Election delays US medtech policymaking
This article was originally published in Clinica
Executive Summary
The US presidential election and changeover from the Clinton to the Bush administration is beginning to have an impact on US FDA policymaking, according to agency officials. On the day President Bush took office in January, his chief of staff announced that final rules announced in the dying days of the Clinton administration would be delayed for 60 days to give the new administration time to review them.